# Sugammadex and Smoker's Neuromuscular Block

> **NCT05313100** · PHASE4 · COMPLETED · sponsor: **Duzce University** · enrollment: 40 (actual)

## Conditions studied

- Neuromuscular Blockade
- Smoking

## Interventions

- **DRUG:** sugammadex

## Key facts

- **NCT ID:** NCT05313100
- **Lead sponsor:** Duzce University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-01
- **Final completion:** 2013-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05313100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05313100, "Sugammadex and Smoker's Neuromuscular Block". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05313100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*